Observation of Brillouin scattering in a high-index doped silica chip waveguide

Autor: Zerbib, M., Hoang, V. T., Beugnot, J. C., Huy, K. P., Little, B., Chu, S. T., Moss, D. J., Morandotti, R., Wetzel, B., Sylvestre, T.

We report the observation of Brillouin backscattering in a 50-cm long spiral high-index doped silica chip waveguide and measured a Brillouin frequency shift of 16 GHz which is in very good agreement with theoretical predictions and numerical simulati

Externí odkaz: http://arxiv.org/abs/2305.11502

Basal/squamous and mixed subtype bladder cancers present poor outcomes after neoadjuvant chemotherapy in the VESPER trial

Autor: Pignot, G., Fendler, J.P., Guy, L., Verhoest, G., Mottet, N., Doerfler, A., Abadie-Lacourtoisie, S., Azzouzi, A., Mongiat, P., Geoffrois, L., Eschwege, P., Di Fiore, F., Roubaud, G., Hoepffner, J.L., Barthelemy, P., Lang, H., Voog, E., Mandron, E., Tourani, J.M., Serrrate, C., Colau, A., Saldana, C., de La Taille, A., Nguyen, T., Kleinclauss, F., Loriot, Y., Irani, J., Eymard, J.C., Larre, S., Huillard, O., Zerbib, M., Rolland, F., Rigaud, J., Houede, N., Droupy, S., Malouf, G., Roupret, M., Vieillot, S., Letang, N., Lharidon, T., Gaschignard, N., Hilgers, W., Davin, J.L., Groeneveld, C.S., Pfister, C., Culine, S., Harter, V., Krucker, C., Fontugne, J., Dixon, V., Sirab, N., Bernard-Pierrot, I., de Reyniès, A., Radvanyi, F., Allory, Y.

Publikováno v: In Annals of Oncology

Re: Association of oncofetal protein expression with clinical outcomes in patients with urothelial carcinoma of the bladder: E. Xylinas, E. K. Cha, F. Khani, L. A. Kluth, M. Rieken, B. G. Volkmer, R. Hautmann, R. Küfer, Y.-T. Chen, M. Zerbib, M. A. Rubin, D. S. Scherr, S. F. Shariat and B. D. Robinson J Urol 2014;191:830-841.

Autor: Szarvas T; Department of Urology, Vienna General Hospital, Medical University of Vienna, Vienna, Austria; Department of Urology and Institute of Pathology and Neuropathology, University of Duisburg-Essen, Essen, Germany. Electronic address: sztibusz@gmail.com., Rübben H; Department of Urology, Vienna General Hospital, Medical University of Vienna, Vienna, Austria; Department of Urology and Institute of Pathology and Neuropathology, University of Duisburg-Essen, Essen, Germany., Reis H; Department of Urology, Vienna General Hospital, Medical University of Vienna, Vienna, Austria; Department of Urology and Institute of Pathology and Neuropathology, University of Duisburg-Essen, Essen, Germany.

Publikováno v: The Journal of urology [J Urol] 2014 Aug; Vol. 192 (2), pp. 617-8. Date of Electronic Publication: 2014 May 02.

A bispecific antibody targeting EGFR and AXL delays resistance to osimertinib.

Autor: Simoni-Nieves A; Departments of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot 76100, Israel., Lindzen M; Departments of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot 76100, Israel., Giri S; Departments of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot 76100, Israel., Gupta N; Departments of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot 76100, Israel., Chatterjee R; Departments of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot 76100, Israel., Selvadurai BR; Departments of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot 76100, Israel., Van Daele M; Departments of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot 76100, Israel., Love D; Departments of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot 76100, Israel., Haga Y; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan., Romaniello D; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40126 Bologna, Italy., Salame TM; Flow Cytometry Unit, Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot 76100, Israel., Zerbib M; Department of Veterinary Resources, Weizmann Institute of Science, Rehovot 76100, Israel., Oren R; Department of Veterinary Resources, Weizmann Institute of Science, Rehovot 76100, Israel., Tsutsumi Y; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan; Global Center for Medical Engineering and Informatics, Osaka University, Osaka 565-0871, Japan; Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Osaka 565-0871, Japan., Lauriola M; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40126 Bologna, Italy., Marrocco I; Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, 00168 Rome, Italy. Electronic address: ilaria.marrocco@unicatt.it., Yarden Y; Departments of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot 76100, Israel. Electronic address: yosef.yarden@weizmann.ac.il.

Publikováno v: Cell reports. Medicine [Cell Rep Med] 2024 Sep 17; Vol. 5 (9), pp. 101703. Date of Electronic Publication: 2024 Aug 30.

Efficacy of an AAV vector encoding a thermostable form of glucocerebrosidase in alleviating symptoms in a Gaucher disease mouse model.

Autor: Milenkovic I; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, 7610001, Israel.; Department of Neurology, Medical University of Vienna, Vienna, Austria., Blumenreich S; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, 7610001, Israel., Hochfelder A; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, 7610001, Israel., Azulay A; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, 7610001, Israel., Biton IE; Department of Veterinary Resources, Weizmann Institute of Science, Rehovot, 7610001, Israel., Zerbib M; Department of Veterinary Resources, Weizmann Institute of Science, Rehovot, 7610001, Israel., Oren R; Department of Veterinary Resources, Weizmann Institute of Science, Rehovot, 7610001, Israel., Tsoory M; Department of Veterinary Resources, Weizmann Institute of Science, Rehovot, 7610001, Israel., Joseph T; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, 7610001, Israel., Fleishman SJ; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, 7610001, Israel., Futerman AH; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, 7610001, Israel. tony.futerman@weizmann.ac.il.

Publikováno v: Gene therapy [Gene Ther] 2024 Sep; Vol. 31 (9-10), pp. 439-444. Date of Electronic Publication: 2024 Aug 15.